
Opinion|Videos|December 23, 2024
Overview of Novel Treatments for Retinal Vascular Diseases
A panelist discusses novel treatments for retinal vascular diseases, including faricimab, aflibercept, and port delivery system with ranibizumab.
Advertisement
Video content above is prompted by the following:
Could you briefly provide an overview of the new treatments available for retinal vascular diseases?
- Faricimab
- Aflibercept 8mg
- Port delivery system with ranibizumab
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: New horizons in research and risk management for ROP
2
FLORetina 2025: Remotely managing patients with neovascular age-related macular degeneration
3
FLORetina 2025: Antithrombotic use examined in wet AMD submacular hemorrhage
4
FLORetina 2025: Enrico Borrelli on reframing retinal disease through the lens of choroidal health
5













































